Use of Coronary Artery Calcium Quantification and Distribution for Coronary Vascular Disease Risk Reclassification in a Primary Prevention Setting

被引:0
|
作者
Ali, Adel Hajj [1 ]
Nakhla, Michael [1 ]
Cho, Leslie [1 ]
Seballos, Raul [1 ]
Lang, Richard [1 ]
Feinleib, Steve [1 ]
Flamm, Scott [1 ]
Schoenhagen, Paul [1 ]
Wang, Tom [1 ]
Desai, Milind Y. [1 ]
机构
[1] Cleveland Clin, Heart Vasc Thorac Inst HVTI, Cleveland, OH 44195 USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2023年 / 206卷
关键词
atherosclerosis; calcium score; coronary artery disease; primary prevention; risk; score; GLOBAL CARDIOVASCULAR RISK; C-REACTIVE PROTEIN; CALCIFICATION; ASSOCIATION; DIAGNOSIS; EVENTS; UPDATE; LP(A); SCORE; MESA;
D O I
10.1016/j.amjcard.2023.08.054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a large screening program of asymptomatic middle-aged individuals, we sought to assess the degree of risk reclassification provided by comparing multiethnic study on subclinical atherosclerosis coronary artery calcium scoring (CACS) versus atherosclerotic cardiovascular disease (ASCVD) and Reynolds risk score (RRS) score. All 5,324 consecutive patients (aged 57 +/- 8 years, 76% male) who underwent CACS screening at the Cleveland Clinic as part of a primary prevention executive health between March 16 and October 21 were included. The 10-year ASCVD, RRS, and multiethnic study on subclinical atherosclerosis CACS (MESA-CACS) risk scores were calculated and categorized as <1, 1 to 4.99, 5 to 9.99, and >= 10%. Compared with ASCVD, using MESA-CACS resulted in a downgraded risk in 1,667 subjects (31%), whereas 738 (14%) had an upgrade in risk (total of 45% reclassification). Similarly, compared with RRS, using MESA-CACS resulted in an upgraded risk in 797 (15%) and a downgrade in 1,380 (26%) subjects (total of 41% reclassification). However, by further dividing by the distribution of the coronary calcification, ASCVD overestimates the risk only for patients with coronary artery calcium (CAC) in 0 or 1 coronary artery only, whereas MESA-CACS overestimates if the CAC was noted in >= 2 arteries. Similarly, RRS only overestimates the risk for patients with 0 CAC, whereas it underestimates the risk for patients with any CAC. In conclusion, the use of MESA-CACS, along with CAC distribution in primary prevention clinics, results in differential and significant reclassification of traditional scores when calculating the 10-years coronary vascular disease risk. Overall, RRS underestimates and ASCVD overestimates the cardiovascular disease risk compared with MESA-CACS.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:303 / 308
页数:6
相关论文
共 50 条
  • [1] Reclassification of coronary heart disease risk in a primary prevention setting: traditional risk factor assessment vs. coronary artery calcium scoring
    Alashi, Alaa
    Lange, Richard
    Seballos, Raul
    Feinleib, Steven
    Sukol, Roxanne
    Cho, Leslie
    Schoenhagen, Paul
    Griffin, Brian P.
    Flamm, Scott D.
    Desai, Milind Y.
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2019, 9 (03) : 214 - 220
  • [2] Screening for Premature Coronary Artery Disease (CAD) using Coronary Artery Calcium (CAC) Score: A Primary Prevention Pilot Study
    Ruslan, Mohd M.
    Shawal, Mohd F. M.
    Norzailin, A. B.
    Shathiskumar, G.
    Tiau, W. J.
    Oteh, M.
    Hamdi, Hamat C. H.
    MEDICINE AND HEALTH, 2021, 16 (01): : 134 - 149
  • [3] Coronary Artery Calcium Scanning The Key to the Primary Prevention of Coronary Artery Disease
    Hecht, Harvey S.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2014, 43 (04) : 893 - +
  • [4] The role of coronary artery calcium in allocating pharmacotherapy for primary prevention of cardiovascular disease: The ABCs of CAC
    Maniar, Yash
    Blumenthal, Roger S.
    Alfaddagh, Abdulhamied
    CLINICAL CARDIOLOGY, 2022, 45 (11) : 1107 - 1113
  • [5] The role of coronary artery calcium estimation in the primary prevention strategy for cardiovascular diseases
    Kolesnyk, M. Yu.
    ZAPOROZHYE MEDICAL JOURNAL, 2023, 25 (05) : 447 - 454
  • [6] Coronary Artery Calcium to Improve the Efficiency of Randomized Controlled Trials in Primary Cardiovascular Prevention
    Cainzos-Achirica, Miguel
    Bittencourt, Marcio Sommer
    Osei, Albert D.
    Haque, Waqas
    Bhatt, Deepak L.
    Blumenthal, Roger S.
    Blankstein, Ron
    Ray, Kausik K.
    Blaha, Michael J.
    Nasir, Khurram
    JACC-CARDIOVASCULAR IMAGING, 2021, 14 (05) : 1005 - 1016
  • [7] Prevalence of coronary artery disease across the Framingham risk categories: coronary artery calcium scoring and MSCT coronary angiography
    Nucifora, Gaetano
    Schuijf, Joanne D.
    van Werkhoven, Jacob M.
    Jukema, J. Wouter
    Djaberi, Roxana
    Scholte, Arthur J. H. A.
    de Roos, Albert
    Schalij, Martin J.
    van der Wall, Ernst E.
    Bax, Jeroen J.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2009, 16 (03) : 368 - 375
  • [8] Polygenic risk, aspirin, and primary prevention of coronary artery disease
    Yu, Chenglong
    Natarajan, Pradeep
    Patel, Aniruddh P.
    Bhatia, Harpreet S.
    Khera, Amit, V
    Neumann, Johannes T.
    Tsimikas, Sotirios
    Wolfe, Rory
    Nicholls, Stephen J.
    Reid, Christopher M.
    Zoungas, Sophia
    Tonkin, Andrew M.
    Mcneil, John J.
    Lacaze, Paul
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024,
  • [9] Subclinical cardiovascular disease and utility of coronary artery calcium score
    Saydam, Cihan Durmus
    IJC HEART & VASCULATURE, 2021, 37
  • [10] Re-Evaluation of Cardiovascular Disease Risk and Primary Prevention Treatments with Coronary Artery Calcium Scoring in Primary Prevention Patients
    Arslan, Abdulla
    Aytemiz, Fatih
    Isiklar, Iclal
    Ozkaya, Oyku Gulmez
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)